Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP9-3 Inhibitors

KRTAP9-3 inhibitors refer to a class of chemical compounds that target the Keratin-Associated Protein 9-3 (KRTAP9-3) gene or its protein product. KRTAP proteins are a large family of structural proteins that contribute to the formation and regulation of keratin fibers, which are the fundamental components of hair, nails, and the outer layer of skin. KRTAP9-3 specifically is one of these proteins, and its expression is linked to the organization and physical properties of keratinized tissues. Inhibitors of KRTAP9-3 are designed to interfere with the normal function or expression of this protein, potentially by binding to active sites on the protein or influencing the transcription or translation processes involved in its production.

From a biochemical perspective, KRTAP9-3 inhibitors may function through a variety of mechanisms, including the disruption of protein-protein interactions within keratin fibers or the modification of post-translational processes that affect keratin stability. These inhibitors could potentially act by altering the conformation of the KRTAP9-3 protein, thereby hindering its ability to integrate into keratin structures. Alternatively, they may block signal transduction pathways responsible for the regulation of KRTAP9-3 gene expression, effectively reducing its production. Understanding the molecular structure and functional dynamics of these inhibitors is critical for advancing our knowledge of keratin biology, and their study can offer insights into the complex processes that govern cellular differentiation, tissue integrity, and the overall biophysical properties of keratin-rich structures.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

HSP90 inhibitor that can destabilize client proteins, potentially affecting KRTAP9-3 stability.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$127.00
$572.00
$4090.00
$20104.00
20
(1)

Compound known to disrupt cytoskeletal proteins, which could affect KRTAP9-3's interaction with keratins.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Protein synthesis inhibitor that can reduce overall protein levels, potentially reducing KRTAP9-3 expression.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Proteasome inhibitor that can increase protein levels, potentially affecting KRTAP9-3 turnover.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Histone deacetylase inhibitor that can alter gene expression, potentially affecting KRTAP9-3 expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor that can affect gene expression, potentially influencing KRTAP9-3.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$67.00
$306.00
2
(1)

Cyclin-dependent kinase inhibitor that can disrupt cell cycle, potentially affecting KRTAP9-3 levels.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

SERCA pump inhibitor that can induce ER stress, potentially impacting KRTAP9-3 folding or stability.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Signaling molecule that can regulate gene expression, potentially affecting KRTAP9-3 levels.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Lysosomotropic agent that can raise lysosomal pH, potentially affecting KRTAP9-3 degradation.